Therapy for colon carcinoma xenografts with bispecific antibody- targeted, iodine-131-labeled bivalent hapten

Cancer

Volumn 80, Issue 12 SUPPL., 1997, Pages 2618-2623

  Gautherot, Emmanuel ^a   Bouhou, Jamila ^a   Le Doussal, Jean Marc ^b   Manetti, Corine ^a   Martin, Marie ^a   Rouvier, Eric ^a   Barbet, Jacques ^a  

^a Immunotech   (France)

^b UNIVERSITY OF LAUSANNE   (Switzerland)

Author keywords

Bispecific antibody; Colon carcinoma; Iodine 131; Pretargeting; Radioimmunotherapy

Indexed keywords

BISPECIFIC ANTIBODY; CARCINOEMBRYONIC ANTIGEN MONOCLONAL ANTIBODY; IMMUNOGLOBULIN F(AB')2 FRAGMENT; IMMUNOGLOBULIN G; IODOGEN; MONOCLONAL ANTIBODY I 131; MONOCLONAL ANTIBODY IN 111; PENTETATE INDIUM IN 111; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; CANCER CELL CULTURE; CANCER GRAFT; CANCER IMMUNOTHERAPY; CANCER RADIOTHERAPY; COLON CARCINOMA; CONFERENCE PAPER; CONTROLLED STUDY; DOSE CALCULATION; DRUG DISTRIBUTION; FEMALE; INTRAVENOUS DRUG ADMINISTRATION; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; RADIOIMMUNOTHERAPY; TOXICITY TESTING; XENOGRAFT;

EID: 0031456004     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(sici)1097-0142(19971215)80:12+<2618::aid-cncr37>3.0.co;2-d     Document Type: Conference Paper

References (18)

1. Press OW, Eary JF, Appelbaum FR, Martin PJ, Nelp WB, Glenn S, et al. Phase II trial of I-131-B1 (anti-CD20) antibody therapy with autologous stem cell transplantation for relapsed B cell lymphomas. Lancet 1995; 346:336-40.
2. 131I-anti-B1 (anti-CD20) antibody. N Engl J Med 1993; 329:459-65.
3. 2 antibodies. Br J Cancer 1994; 70:521-5.
4. Juweid M, Sharkey RM, Behr T, Swayne LC, Herskovic T, Pereira M, et al. Radioimmunotherapy of medullary thyroid cancer with iodine-131-labeled anti-CEA antibodies. J Nucl Med 1996; 37:905-11.
5. Siccardi AG, Paganelli G, Pontiroli AE, Pelagi M, Magnani P, Viale G, et al. In vivo imaging of chromagrin A-positive endocrine tumors by three-step monoclonal antibody targeting. Eur J Nucl Med 1996; 23:1455-9.
6. Ratliff B, Reno J, Axworthy D, Fritzberg A, Su FM, Appelbaum J, et al. Performance of antibody streptavidin pretargeting in patients: initial results [abstract]. J Nucl Med 1995; 36:225P.
7. Le Doussal JM, Martin M, Gautherot E, Delaage M, Barbet J. In vitro and in vivo targeting of radiolabeled monovalent and divalent haptens with dual specificity monoclonal antibody conjugates: enhanced divalent hapten affinity for cell-bound antibody conjugate. J Nucl Med 1989; 30:1358-66.
8. Le Doussal JM, Chetanneau A, Guyon-Gruaz A, Martin M, Gautherot E, Lehur PA, et al. Bispecific monoclonal antibody-mediated targeting of an indium-111-labeled DTPA dimer to primary colorectal tumors: pharmacokinetics, biodistribution, scintigraphy and immune response. J Nucl Med 1993; 34:1662-71.
9. Peltier P, Curtet C, Chatal JF, Le Doussal JM, Daniel G, Aillet G, et al. Radioimmunodetection of medullary thyroid cancer using a bispecific anti-CEA/anti-indium-DTPA antibody and an indium-111-labeled DTPA dimer. J Nucl Med 1993; 34:1267-73.
10. 111In-labelled bivalent hapten and a bispecific antibody conjugate. Nucl Med Commun 1994; 15:972-80.
11. 131I-labeled bivalent hapten in patients with medullary thyroid carcinoma and small-cell lung cancer. J Nucl Med 1996; 37:1853-9.
12. 2 antibody containing thioether-linked Fab′γ fragments. J Immunol 1987; 139:2367-75.
13. Le Doussal JM, Gruaz-Guyon A, Martin M, Gautherot E, Delaage M, Barbet J. Targeting of indium-111-labeled bivalent hapten to human melanoma mediated by bispecific monoclonal antibody conjugates: imaging of tumors hosted in nude mice. Cancer Res 1990; 50:3445-52.
14. Devys A, Thedrez P, Gautherot E, Faivre-Chauvet A, Saï-Maurel C, Rouvier E, et al. Comparative targeting of human colon-carcinoma multicell spheroids using one- and two-step (bispecific antibody) techniques. Int J Cancer 1996; 67:883-91.
15. Johns HE, Cunningham JR. The physics of radiology. In: Friedmann M, editor. Monograph in the Bannerstane division of American lectures in radiation therapy. Springfield, IL: Charles C. Thomas, 1978:564-74.
16. Blumenthal RD, Sharkey RM, Natale AM, Kashi R, Wong G, Goldenberg DM. Comparison of equitoxic radioimmunotherapy and chemotherapy in the treatment of human colonic cancer xenografts. Cancer Res 1994; 54:142-51.
17. Pedley RB, Boden JA, Boden R, Boxer GM, Flynn AA, Keep PA, et al. Ablation of colorectal xenografts with combined radioimmunotherapy and tumor blood flow-modifying agents. Cancer Res 1996; 56:3293-300.
18. Buchegger F, Rojas A, Bischof-Delaloye A, Vogel CA, Mirimanoff RO, Coucke P, et al. Combined radioimmunotherapy and radiotherapy of human colon carcinoma grafted in nude mice. Cancer Res 1995; 55:83-9.